Print   



BEXIMCO PHARMACEUTICALS LTD. 

17, DHANMONDI R.A, ROAD NO. 2, 

DHAKA-1205

News Release

May 14, 2009

NOTICE OF THE THIRTY-THIRD ANNUAL GENERAL MEETING

Notice is hereby given that the THIRTY-THIRD ANNUAL GENERAL MEETING of the Shareholders of Beximco Pharmaceuticals Limited will be held on Tuesday, 16th June, 2009 at 9.30 a.m. at 1, Shahbag C/A, Dhaka, to transact the following business: 

Agenda

1.    To receive, consider and adopt the Audited Financial Statements of the Company for the year ended 31st December
       2008, together with reports of the Auditors and the Directors thereon. 

2.    To elect Directors.

3.    To confirm the appointment of Mr. Nazmul Hassan as Managing Director of the Company for a period of 5 years 
       effective from 7th May 2009.

4.    To declare 10% Cash and 20% Stock Dividend.

5.    To appoint Auditors for the year 2009 and to fix their remuneration.

6.    To transact any other business of the Company with the permission of the Chair.

By order of the Board,

Sd/-

( MD. ASAD ULLAH, FCS ) 

Company Secretary

    

    

NOTES

(1)    The Record Date shall be on 25th May, 2009. The Shareholders whose names will appear in the Share Register of the 
         Company or in the Depository Register on that date will be entitled to attend the Annual General Meeting and to receive the
         dividend.

(2)    A member entitled to attend and vote at the General Meeting may appoint a Proxy to attend and vote in his/her stead. The Proxy
         Form, duly stamped, must be deposited at the Registered office of the Company not later than 48 hours before the time fixed for 
         the meeting.

(3)    Admission to the meeting room will be strictly on production of the attendance slip sent with the Notice as well as verification of 
        signature of Member(s) and/or proxy-holder(s). 

For further enquiries please contact:

 

Beximco Pharma

Nazmul Hassan, CEO

MD. ASAD ULLAH, FCS, Company Secretary

Tel: +880 2 861 9151, ext.2080

 

Libertas Capital

Jakob Kinde / Anthony Rowland

Tel: +44 (0)20 7569 9650

 

Financial Dynamics

Jonathan Birt / Susan Quigley

Tel: +44 (0)20 7269 7169

 

Notes to Editors

 

About Beximco Pharmaceuticals Limited

Founded in 1976 and based in Dhaka, Bangladesh, BPL manufactures and sells generic pharmaceutical formulation products, active pharmaceutical ingredients and intravenous fluids. The Company also manufactures and markets its own branded generics for almost all diseases. The Company also undertakes contract manufacturing for multinational pharmaceutical companies. The Company operates from a 20 acre site in Dhaka and currently employs over 2,400 staff.

The Company's products are sold to retail outlets, medical institutions and other pharmaceutical manufacturers in  Bangladesh, in regional markets such as Sri Lanka, Nepal, Bhutan, Vietnam, Cambodia and Myanmar and in other markets overseas, principally in East Africa, Pacific Island and Central American countries and South East Asia, including  Singapore and Hong Kong.

ENDNOAUORSRKKRVAAR